Becker's Healthcare February 10, 2022
As demand for COVID-19 testing and vaccination dwindles, CVS Health must prove that it can continue to grow and maintain customers, CNBC reported Feb. 9.
Pandemic-related services drove CVS sales and customer engagement as the pharmacy administered more than 32 million COVID-19 tests and more than 59 million COVID-19 vaccines. But as cases around the country decrease, CVS will need to work on maintaining its ambitions of becoming a healthcare destination, according to the report.
On a Feb. 9 earnings call, Shawn Guertin, chief financial officer of CVS, said he expects COVID-19 vaccines to drop by 70 percent to 80 percent and in-store testing to decline by 40 percent to 50 percent, compared to 2021.
The only exception coming...